We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$415M
AUM Growth
+$44.4M
Cap. Flow
+$47.9M
Cap. Flow %
11.55%
Top 10 Hldgs %
45.62%
Holding
96
New
27
Increased
21
Reduced
16
Closed
26

Top Buys

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$11.3M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$10.7M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
+$9.88M
4
BEAT
BioTelemetry, Inc.
BEAT
+$8.09M
5
ELV icon
Elevance Health
ELV
+$8.01M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$18.6M
2
GILD icon
Gilead Sciences
GILD
+$16M
3
CVS icon
CVS Health
CVS
+$13.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$10.6M
5
NVO
Novo Nordisk
NVO
+$8.47M

Sector Composition

Rank Sector Weight
1 Healthcare 69.13%
2 Technology 1.01%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPPI
26
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$5.2M 1.25%
604,019
+50,000
+9% +$447K
VRTX icon
27
Vertex Pharmaceuticals
VRTX
$123B
$5.18M 1.25%
28,232
– –
ICLR icon
28
Icon
ICLR
$13.7B
$4.7M 1.13%
30,530
+8,059
+36% +$1.13M
ITGR icon
29
Integer Holdings
ITGR
$3.38B
$4.69M 1.13%
+55,844
New +$4.18M
HRC
30
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$4.41M 1.06%
42,182
+32,500
+336% +$3.29M
GMED icon
31
Globus Medical
GMED
$11.1B
$4.35M 1.05%
102,827
-100,000
-49% -$4.34M
MOH icon
32
Molina Healthcare
MOH
$10.4B
$4.29M 1.04%
30,000
-14,928
-33% -$2.04M
AVTR icon
33
Avantor
AVTR
$9.82B
$4.23M 1.02%
+221,587
New +$3.94M
UBER icon
34
Uber
UBER
$145B
$4.17M 1.01%
+90,000
New +$3.82M
HROW icon
35
Harrow
HROW
$1.44B
$4.1M 0.99%
471,114
-70,000
-13% -$386K
CHRS icon
36
Coherus Oncology
CHRS
$216M
$4.07M 0.98%
+184,366
New +$3.2M
NTRA icon
37
Natera
NTRA
$36.3B
$4.01M 0.97%
+145,500
New +$3.21M
IDXX icon
38
PUT
Idexx Laboratories
IDXX
$45B
$3.96M 0.96%
14,400
-2,500
-15% -$616K
STRO icon
39
Sutro Biopharma
STRO
$387M
$3.86M 0.93%
33,906
-5,974
-15% -$658K
ZBH icon
40
Zimmer Biomet
ZBH
$18.8B
$3.84M 0.93%
33,609
+2,709
+9% +$317K
GYRE icon
41
Gyre Therapeutics
GYRE
$629M
$3.79M 0.91%
68,606
+8,032
+13% +$502K
LITS
42
Lite Strategy Inc
LITS
$32M
$3.77M 0.91%
75,504
-42,328
-36% -$2.48M
SNN icon
43
Smith & Nephew
SNN
$13.8B
$3.31M 0.8%
76,102
-34,225
-31% -$1.42M
HSACU
44
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
$3.25M 0.78%
+307,000
New +$3.2M
FOMX
45
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$3.08M 0.74%
1,295,669
– –
BNGO icon
46
Bionano Genomics
BNGO
$12.4M
$2.69M 0.65%
2,533
-31
-1% -$63.3K
CCRN
47
DELISTED
Cross Country Healthcare
CCRN
$2.43M 0.59%
+258,727
New +$1.99M
EBS icon
48
Emergent Biosolutions
EBS
$379M
$2.34M 0.56%
48,400
-131,756
-73% -$6.31M
BCRX icon
49
BioCryst Pharmaceuticals
BCRX
$2.42B
$1.98M 0.48%
+522,863
New +$3.15M
DOVA
50
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$1.91M 0.46%
+135,133
New +$1.29M
1
2
3 4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sio Capital Management held 96 positions worth $415M, up 12% from $370M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sio Capital Management deployed $47.9M of net new capital in Q2 2019, opening 27 new positions and adding to 21 existing holdings. Its largest new stake was La Jolla Pharmaceutical Company: 1,310,367 shares worth $12.1M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 81% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was CVS Health, an estimated $13.6M trimmed.

  • Sio Capital Management's largest Q2 2019 buy was La Jolla Pharmaceutical Company: 1,310,367 shares worth $12.1M.
  • Sio Capital Management added most to Wellcare Health Plans, Inc. in Q2 2019, an estimated $11.3M increase.
  • Sio Capital Management's biggest Q2 2019 reduction was CVS Health, cutting an estimated $13.6M.
  • Sio Capital Management fully exited Biogen in Q2 2019, selling an estimated $18.6M.
  • Sio Capital Management's ten largest holdings make up 46% of its $415M portfolio in Q2 2019.
  • Sio Capital Management opened 27 new positions and closed 26 in Q2 2019.
  • Sio Capital Management's portfolio value rose 12% quarter-over-quarter to $415M.

Based on Sio Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.